Aqr Capital Management LLC Rigel Pharmaceuticals Inc Transaction History

Aqr Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $20,840 - $99,224	-31,105 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $33,042 - $51,349	-14,884 Reduced 32.36%	31,105 $93,000
Q1 2021 May 17, 2021	SELL	$3.35 - $4.93 $11,564 - $17,018	-3,452 Reduced 6.98%	45,989 $157,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $59,229 - $94,262	25,204 Added 103.99%	49,441 $173,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $43,141 - $100,098	24,237 New	24,237 $58,000
Q1 2019 May 14, 2019	SELL	$2.0 - $2.65 $78,780 - $104,383	-39,390 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $46,569 - $75,227	-22,389 Reduced 36.24%	39,390 $91,000
Q3 2018 Nov 15, 2018	BUY	$2.6 - $3.59 $64,898 - $89,609	24,961 Added 67.8%	61,779 $198,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $104,194 - $151,321	36,818 New	36,818 $104,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.95B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.